or Try an Advanced Search...

    Technical Analysis for PCVX - Vaxcyte, Inc.

    Grade Last Price % Change Price Change
    D 88.54 0.17% 0.15
    PCVX closed up 0.17 percent on Friday, November 22, 2024, on 1.48 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical PCVX trend table...
    Date Alert Name Type % Chg
    Multiple of Ten Bearish Other 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Multiple of Ten Bearish Other 0.17%
    Wide Bands Range Expansion 0.17%
    Oversold Stochastic Weakness 0.17%
    Lower Bollinger Band Walk Weakness 3.00%
    Wide Bands Range Expansion 3.00%
    Oversold Stochastic Weakness 3.00%
    Older End-of-Day Signals for PCVX ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 15 hours ago
    Up 3% about 16 hours ago
    Up 2% about 18 hours ago
    60 Minute Opening Range Breakout about 18 hours ago
    Up 1% about 19 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PCVX Chart by TradingView
    Basic chart:

    Profile

    Vaxcyte, Inc. a biopharmaceutical company, develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate, and complex antigen-based vaccines. The company has a license to Sutro Biopharma's Xpress CF platforms for cell free protein synthesis and site-specific conjugation. Vaxcyte, Inc. was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May, 2020. The company was incorporated in 2013 and is based in Foster City, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Life Sciences Infectious Diseases Vaccines Vaccination Virology

    Is PCVX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 17 Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
    Nov 12 Vaxcyte gets FDA Breakthrough Therapy Designation for its pneumococcal disease treatment
    Nov 12 Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs
    Nov 7 We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely
    Nov 6 Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight
    Nov 5 Vaxcyte GAAP EPS of -$0.83 beats by $0.31
    Nov 5 Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update
    Nov 1 Should You Consider Investing in Vaxcyte (PCVX)?
    Sep 14 Vaxcyte, Inc. (PCVX): Among Hedge Funds’ Top Biotech Stock Picks
    Sep 11 Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference
    See more PCVX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 121.055
    52 Week Low 48.81
    Average Volume 1,093,204
    200-Day Moving Average 83.22
    50-Day Moving Average 107.89
    20-Day Moving Average 99.06
    10-Day Moving Average 91.56
    Average True Range 4.72
    RSI (14) 29.58
    ADX 25.67
    +DI 17.51
    -DI 25.37
    Chandelier Exit (Long, 3 ATRs) 101.84
    Chandelier Exit (Short, 3 ATRs) 98.68
    Upper Bollinger Bands 116.61
    Lower Bollinger Band 81.51
    Percent B (%b) 0.2
    BandWidth 35.44
    MACD Line -6.09
    MACD Signal Line -4.74
    MACD Histogram -1.3513
    Fundamentals Value
    Market Cap 9.55 Billion
    Num Shares 108 Million
    EPS -4.73
    Price-to-Earnings (P/E) Ratio -18.72
    Price-to-Sales 0.00
    Price-to-Book 5.76
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 93.62
    Resistance 3 (R3) 93.98 92.65 92.77
    Resistance 2 (R2) 92.65 91.36 92.47 92.49
    Resistance 1 (R1) 90.60 90.56 91.62 90.23 92.21
    Pivot Point 89.27 89.27 89.78 89.08 89.27
    Support 1 (S1) 87.21 87.97 88.24 86.85 84.87
    Support 2 (S2) 85.88 87.17 85.70 84.59
    Support 3 (S3) 83.83 85.88 84.31
    Support 4 (S4) 83.46